Expandable stents for malignant esophageal disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 21, Issue 3, 2011, Pages 377-388

  Vleggaar, F P ^a   Siersema, P D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cancer; Dysphagia; Esophagus; Expandable; Stent

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ARGON PLASMA COAGULATION; BARE METAL STENT; BLEEDING; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; DYSPHAGIA; ESOPHAGOBRONCHIAL FISTULA; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; FEEDING DISORDER; FOOD OBSTRUCTION; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; MEDIASTINITIS; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTHESIS FAILURE; RETROSTERNAL PAIN; REVIEW; SMALL INTESTINE PERFORATION; STENT THROMBOSIS; TISSUE GROWTH;

DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; HUMANS; PALLIATIVE CARE; PROSTHESIS FAILURE; RECURRENCE; STENTS; TRACHEOESOPHAGEAL FISTULA;

EID: 79959239033     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2011.04.006     Document Type: Review

References (45)

1. Siersema P.D. Esophageal cancer. Gastroenterol Clin North Am 2008, 37:943-964.
2. Homs M.Y., Eijkenboom W.M., Siersema P.D. Single-dose brachytherapy for the palliative treatment of esophageal cancer. Endoscopy 2005, 37:1143-1148.
3. Fleischer D., Sivak M.V. Endoscopic Nd: YAG laser therapy as palliation for esophagogastric cancer. Parameters affecting initial outcome. Gastroenterology 1985, 89:827-831.
4. Okunaka T., Kato H., Conaka C., et al. Photodynamic therapy for esophageal carcinoma. Surg Endosc 1990, 4:150-153.
5. Wadleigh R.G., Abbasi S., Korman L. Palliative ethanol injection of unresectable advanced esophageal carcinoma combined with chemoradiation. Am J Med Sci 2006, 331:110-112.
6. Burris H.A., Vogel C.L., Castro D., et al. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 1998, 118:496-503.
7. Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004, 364:1497-1504.
8. Bergquist H., Wenger U., Johnsson E., et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005, 18:131-139.
9. Adler D.G., Fang J., Wong R., et al. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 2009, 70:614-619.
10. Verschuur E.M., Repici A., Kuipers E.J., et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cancer cardia cancer: a randomized trial. Am J Gastroenterol 2008, 103:304-312.
11. Bona D., Laface L., Bonavina L., et al. Covered nitinol stents for the treatment of esophageal strictures and leaks. World J Gastroenterol 2010, 16:2260-2264.
12. Conio M., Repici A., Battaglia G., et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007, 102:2667-2677.
13. Homs M.Y., Steyerberg E.W., Kuipers E.J., et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004, 36:880-886.
14. Sabharwal T., Hamady M.S., Chui S., et al. A randomized prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third esophageal carcinoma. Gut 2003, 52:922-926.
15. Verschuur E.M., Steyerberg E.W., Kuipers E.J., et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 2007, 65:592-601.
16. Van Boeckel P.G., Repici A., Vleggaar F.P., et al. A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study. Gastrointest Endosc 2010, 71:455-460.
17. Van Boeckel P.G., Siersema P.D., Sturgess R., et al. A new partially covered metal stent for palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2010, 72:1269-1273.
18. Uitdehaag M.J., van Hooft J.E., Verschuur E.M., et al. A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2009, 70:1082-1089.
19. Uitdehaag M.J., Siersema P.D., Spaander M.C., et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc 2010, 71:600-605.
20. Bay J., Penninga L. Small bowel ileus caused by migration of esophageal stent. Ugerskr Laeger 2010, 172:2234-2235. [in Danish].
21. Harries R., Campbell J., Ghosh S. Fractured migrated oesophageal stent fragment presenting as small bowel obstruction three years after insertion. Ann R Coll Surg Engl 2010, 92:W14-W15.
22. Reddy V.M., Sutton C.D., Miller A.S. Terminal ileum perforation as a consequence of a migrated and fractured oesophageal stent. Case Rep Gastroenterol 2009, 15:61-66.
23. Furlong H., Nasr A., Walsh T.N. Gastropleural fistula: a complication of esophageal self-expanding metallic stent migration. Endoscopy 2009, 41:E38-E39.
24. Verschuur E.M., Homs M.Y., Steyerberg E.W., et al. A new esophageal stent design (Niti-S) for the prevention of migration: a prospective follow-up study in 42 patients. Gastrointest Endosc 2006, 63:134-140.
25. Vleggaar F.P. Stent placement in esophageal cancer as a bridge to surgery. Gastrointest Endosc 2009, 70:620-622.
26. Homs M.Y., Hansen B.E., van Blankenstein M., et al. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 2004, 16:163-170.
27. Homs M.Y., Wahab P.J., Kuipers E.J., et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc 2004, 60:695-702.
28. Laasch H.U., Marriott A., Wilbraham L., et al. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002, 225:359-365.
29. Power C., Byrne P.J., Lim K., et al. Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial. Dis Esophagus 2007, 20:466-470.
30. Sabharwal T., Gulati M.S., Fotiadis N., et al. Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol 2008, 23:723-728.
31. Shim C.S., Jung I.S., Cheon Y.K., et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy 2005, 37:335-339.
32. Reed M.F., Mathisen D.J. Tracheoesophageal fistula. Chest Surg Clin N Am 2003, 13:271-289.
33. Ross W.A., Alkassab F., Lynch P.M., et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 2007, 65:70-76.
34. May A., Ell C. Palliative treatment of malignant esophagorespiratory fistulas with Gianturco-Z stents. A prospective clinical trial and review of the literature on covered metal stents. Am J Gastroenterol 1998, 93:532-535.
35. Raijman I., Siddique I., Ajani J., et al. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 1998, 48:172-179.
36. Herth F.J., Peter S., Baty F., et al. Combined airway and oesophageal stenting in malignant airway-oesophageal fistulas: a prospective study. Eur Respir J 2010, 36:1370-1374.
37. Bower M., Jones W., Vessels B., et al. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol 2009, 16:3161-3168.
38. Martin R., Duvall R., Ellis S., et al. The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative car. Surg Endosc 2009, 23:615-621.
39. Siddiqui A.A., Glynn C., Loren D., et al. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus 2009, 22:216-222.
40. Lopes T.L., Eloubeidi M.A. A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer. Dis Esophagus 2010, 23:309-315.
41. Langer F.B., Schoppmann S.F., Prager G., et al. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 2010, 17:470-475.
42. Van Heel N.C., Haringsma J., Spaander M.C., et al. Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc 2010, 72:249-254.
43. Van Heel N.C., Haringsma J., Spaander M.C., et al. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression. Endoscopy 2010, 42:536-540.
44. Verschuur E.M., Kuipers E.J., Siersema P.D. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 2007, 66:1082-1090.
45. Eleftheriadis E., Kotzampassi K. Endoprosthesis implantation at the pharyngo-esophageal level: problems, limitations and challenges. World J Gastroenterol 2006, 12:2103-2108.